» Articles » PMID: 1500537

Identification of Ehrlichia Chaffeensis Morulae in Cerebrospinal Fluid Mononuclear Cells

Overview
Specialty Microbiology
Date 1992 Aug 1
PMID 1500537
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We report a case of ehrlichiosis in a 72-year-old man who developed extreme lethargy, acute renal failure requiring hemodialysis, and respiratory insufficiency requiring intubation. Lumbar puncture performed on the second day of hospitalization revealed significant cellular pleocytosis. Ehrlichia morulae were tentatively identified in mononuclear cells in routinely processed Wright-stained cytospin preparations of cerebrospinal fluid (CSF). Identification was confirmed by a specific immunocytochemical staining procedure. Subsequent identification specifically as Ehrlichia chaffeensis morulae was established by polymerase chain reaction analysis, which revealed E. chaffeensis-specific DNA in CSF, bone marrow, and blood samples; by indirect fluorescent-antibody analysis, the patient developed an antibody titer of 32,768 against E. chaffeensis antigen. The patient responded to intravenous therapy with doxycycline and dexamethasone. Subsequently, neurologic, hematologic, renal, and pulmonary status had returned to baseline at follow-up 12 weeks after admission. To our knowledge, this is the first identification of E. chaffeensis morulae in CSF cells in an infected patient.

Citing Articles

Molecular survey of Anaplasma and Ehrlichia species in livestock ticks from Kassena-Nankana, Ghana; with a first report of Anaplasma capra and Ehrlichia minasensis.

Addo S, Baako B, Bentil R, Addae C, Behene E, Asoala V Arch Microbiol. 2023; 205(3):92.

PMID: 36795247 DOI: 10.1007/s00203-023-03430-1.


Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis.

Piantadosi A, Mukerji S, Ye S, Leone M, Freimark L, Park D mBio. 2021; 12(4):e0114321.

PMID: 34465023 PMC: 8406231. DOI: 10.1128/mBio.01143-21.


Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Garcia-Monco J, Benach J Ann Neurol. 2018; 85(1):21-31.

PMID: 30536421 PMC: 7025284. DOI: 10.1002/ana.25389.


Non-lyme tick-borne diseases: a neurological perspective.

Seraji-Bozorgzad N, Tselis A Curr Neurol Neurosci Rep. 2013; 13(10):388.

PMID: 24014177 DOI: 10.1007/s11910-013-0388-6.


Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007.

Folkema A, Holman R, Dahlgren F, Cheek J, McQuiston J Am J Trop Med Hyg. 2012; 87(3):529-37.

PMID: 22826495 PMC: 3435360. DOI: 10.4269/ajtmh.2012.12-0060.


References
1.
Anderson B, Sumner J, DAWSON J, TZIANABOS T, Greene C, Olson J . Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol. 1992; 30(4):775-80. PMC: 265160. DOI: 10.1128/jcm.30.4.775-780.1992. View

2.
Feinstein D . Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med. 1985; 313(21):1348-50. DOI: 10.1056/NEJM198511213132109. View

3.
McDade J . Ehrlichiosis--a disease of animals and humans. J Infect Dis. 1990; 161(4):609-17. DOI: 10.1093/infdis/161.4.609. View

4.
Harkess J, Stucky D, Ewing S . Neurologic abnormalities in a patient with human ehrlichiosis. South Med J. 1990; 83(11):1341-3. DOI: 10.1097/00007611-199011000-00031. View

5.
Fishbein D, Kemp A, DAWSON J, Greene N, Redus M, Fields D . Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989; 160(5):803-9. DOI: 10.1093/infdis/160.5.803. View